CAUSEY CHRISTOPHER 4
4 · UNITED THERAPEUTICS Corp · Filed Sep 2, 2025
Insider Transaction Report
Form 4
CAUSEY CHRISTOPHER
Director
Transactions
- Exercise/Conversion
Common Stock
2025-09-02$132.30/sh+3,000$396,900→ 7,865 total - Sale
Common Stock
2025-09-02$419.63/sh−1,000$419,630→ 6,865 total - Sale
Common Stock
2025-09-02$430.00/sh−1,000$430,000→ 5,865 total - Sale
Common Stock
2025-09-02$420.00/sh−1,000$420,000→ 4,865 total - Exercise/Conversion
Stock Option
2025-09-02−3,000→ 0 totalExercise: $132.30From: 2018-06-28Exp: 2027-06-28→ Common Stock (3,000 underlying)
Footnotes (1)
- [F1]This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024.